Development of Stability Indicating HPLC–UV Method for Determination of Daclatasvir and Characterization of Forced Degradation Products
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of Stability Indicating HPLC–UV Method for Determination of Daclatasvir and Characterization of Forced Degradation Products
Authors
Keywords
Daclatasvir, HPLC–UV, Degradation products, Tablet dosage forms
Journal
CHROMATOGRAPHIA
Volume 81, Issue 5, Pages 785-797
Publisher
Springer Nature
Online
2018-03-12
DOI
10.1007/s10337-018-3503-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Development and validation of a simple and robust HPLC method with UV detection for quantification of the hepatitis C virus inhibitor daclatasvir in human plasma
- (2017) Giulio Nannetti et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Development and Validation of the Chiral HPLC Method for Daclatasvir in Gradient Elution Mode on Amylose-Based Immobilized Chiral Stationary Phase
- (2016) G. Srinivasu et al. CHROMATOGRAPHIA
- Development and validation of sensitive and rapid UPLC–MS/MS method for quantitative determination of daclatasvir in human plasma: Application to a bioequivalence study
- (2016) Mamdouh R. Rezk et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- A UHPLC–MS/MS method for the quantification of direct antiviral agents simeprevir, daclatasvir, ledipasvir, sofosbuvir/GS-331007, dasabuvir, ombitasvir and paritaprevir, together with ritonavir, in human plasma
- (2016) Alessandra Ariaudo et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Drug Interactions With Direct-Acting Antivirals for Hepatitis C
- (2015) Sarah Burgess et al. ANNALS OF PHARMACOTHERAPY
- Daclatasvir
- (2015) Michael A. Smith et al. ANNALS OF PHARMACOTHERAPY
- Multiplexed LC-MS/MS method for the simultaneous quantitation of three novel hepatitis C antivirals, daclatasvir, asunaprevir, and beclabuvir in human plasma
- (2015) Hao Jiang et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Sofosbuvir
- (2014) Lucia Rose et al. ANNALS OF PHARMACOTHERAPY
- Preclinical Characterization of BMS-791325, an Allosteric Inhibitor of Hepatitis C Virus NS5B Polymerase
- (2014) Julie A. Lemm et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection
- (2014) Nezam Afdhal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Assessment of pharmacokinetic interactions of the HCV NS5A replication complex inhibitor daclatasvir with antiretroviral agents: ritonavir-boosted atazanavir, efavirenz and tenofovir.
- (2013) Marc Bifano et al. ANTIVIRAL THERAPY
- A rugged and accurate liquid chromatography–tandem mass spectrometry method for the determination of asunaprevir, an NS3 protease inhibitor, in plasma
- (2013) Long Yuan et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Integrating Phylodynamics and Epidemiology to Estimate Transmission Diversity in Viral Epidemics
- (2013) Gkikas Magiorkinis et al. PLoS Computational Biology
- Preclinical Profile and Characterization of the Hepatitis C Virus NS3 Protease Inhibitor Asunaprevir (BMS-650032)
- (2012) Fiona McPhee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Liver transplantation in the setting of chronic HCV
- (2012) Norah Terrault BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Natural history of acute and chronic hepatitis C
- (2012) Benjamin Maasoumy et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- A sensitive and accurate liquid chromatography–tandem mass spectrometry method for quantitative determination of the novel hepatitis C NS5A inhibitor BMS-790052 (daclastasvir) in human plasma and urine
- (2012) Hao Jiang et al. JOURNAL OF CHROMATOGRAPHY A
- Genotypic and phenotypic analysis of variants resistant to hepatitis C virus nonstructural protein 5A replication complex inhibitor BMS-790052 in Humans: In Vitro and In Vivo Correlations
- (2011) Robert A. Fridell et al. HEPATOLOGY
- An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases
- (2011) Marc G. Ghany et al. HEPATOLOGY
- Boceprevir for Untreated Chronic HCV Genotype 1 Infection
- (2011) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
- (2011) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evolving epidemiology of hepatitis C virus
- (2010) D. Lavanchy CLINICAL MICROBIOLOGY AND INFECTION
- Hepatitis C virus directly acting antivirals: current developments with NS3/4A HCV serine protease inhibitors
- (2010) S. Naggie et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now